The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in atrophic AMD
S. Ghosh, R. Sharma, S. Bammidi…·D. Sinha
This study identifies the AKT2/SIRT5/TFEB pathway as a therapeutic target for atrophic AMD by showing its role in lysosomal dysfunction and drusen formation in RPE cells.